Reliq Health Technologies, Inc. to Present at GCFF Virtual

HAMILTON, Ontario, Nov. 02, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF) (“Reliq” or the “Company”), a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar medtech market, today announced that its CEO, Dr. Lisa Crossley, will present at the Global Chinese Financial Forum (GCFF) Virtual Conference Main Event – Small Cap Investing on Thursday, November 4, 2021 at 10:25am PDT / 1:25pm EDT.

Presentation Details
Date: Thursday, November 4, 2021
Time: 10:25am PDT / 1:25pm EDT

About GCFF Virtual Conference Main Event – Small Cap investing
The Global Chinese Financial Forum (GCFF) Virtual Conference Main Event – Small Cap Investing will take place on November 4, 2021 virtually. GCFF is the largest conference that caters towards the Chinese investment community in North America. Covering all sectors including Technology, Healthcare, Consumer Goods, Clean-tech and more, the GCFF Main Event will provide its viewers with an up-front look at the latest fast-growing investment opportunities in the small cap world. Join us on November 4th.

Registration is free. For more information and to register, please visit:

About Reliq Health

Reliq Health Technologies is a rapidly growing global medtech company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTC as RQHTF.

“Dr. Lisa Crossley”
CEO and Director

For further information please contact:

Company Contact
Investor Relations at

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc. 

Reliq Health Technologies Inc

Source link

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy